Natera, Inc. (NTRA) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Natera, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.280 financial results conference call. At this time all participants are in a listen only 00:00:04.280 -- 00:00:10.360 mode. Following management's prepared remarks we will hold a question and answer session. 00:00:10.360 -- 00:00:15.180 To ask a question at that time please press star followed by one on your touchstone phone. 00:00:15.180 -- 00:00:19.060 If anyone has difficulty hearing the conference please 00:00:19.060 -- 00:00:23.980 press star zero for operator assistance. As a reminder this conference call is being 00:00:23.980 -- 00:00:27.920 recorded today August 7, 2025. 00:00:27.920 -- 00:00:32.780 I would now turn the conference call over to Michael Brophy, chief financial officer. 00:00:32.780 -- 00:00:35.220 Please go ahead. 00:00:35.360 -- 00:00:38.980 Thanks operator. Good afternoon. Thank you for joining our conference call to discuss 00:00:38.980 -- 00:00:41.760 the results of our second quarter of 2025. 00:00:41.760 -- 00:00:46.760 On the line I'm joined by Steve Chapman, our CEO, Salman Moshkovich, president, clinical 00:00:46.760 -- 00:00:52.360 diagnostics, and Al Coleshin, general manager of oncology and our chief medical officer. 00:00:52.360 -- 00:00:56.280 Today's conference call is being broadcast live via webcast. 00:00:56.280 -- 00:01:01.600 We will be referring to a slide that has been posted to .notera.com. 00:01:01.660 -- 00:01:06.480 A replay of the call will also be posted to our IR site as soon as it's available. 00:01:06.480 -- 00:01:09.500 Starting on slide two, during the course of this conference call we will make forward 00:01:09.500 -- 00:01:12.720 looking statements regarding future events and our anticipated future performance such 00:01:12.720 -- 00:01:16.440 as our operational financial outlo...